1. Home
  2. MOVE vs PHAT Comparison

MOVE vs PHAT Comparison

Compare MOVE & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MOVE

Movano Inc.

HOLD

Current Price

$22.05

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.33

Market Cap

894.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOVE
PHAT
Founded
2018
2018
Country
United States
United States
Employees
32
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
894.0M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
MOVE
PHAT
Price
$22.05
$11.33
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$19.83
AVG Volume (30 Days)
61.6K
1.3M
Earning Date
04-08-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.72
EPS
N/A
N/A
Revenue
$433,000.00
$175,110,000.00
Revenue This Year
$1,460.71
$93.04
Revenue Next Year
$96.77
$58.91
P/E Ratio
N/A
N/A
Revenue Growth
N/A
216.93
52 Week Low
$0.51
$3.92
52 Week High
$34.87
$18.31

Technical Indicators

Market Signals
Indicator
MOVE
PHAT
Relative Strength Index (RSI) 63.63 43.75
Support Level $6.77 $11.04
Resistance Level $34.87 $12.83
Average True Range (ATR) 2.75 0.73
MACD 0.79 -0.13
Stochastic Oscillator 73.44 8.04

Price Performance

Historical Comparison
MOVE
PHAT

About MOVE Movano Inc.

Corvex Inc is an AI cloud computing company that provides computing infrastructure for artificial intelligence workloads, including GPU-accelerated computing, confidential computing, and inference services. Its offerings are used by government and enterprise customers, including those with regulated workloads, to support the deployment and operation of AI models and data processing systems. The company generates revenue from the sale of Wellness Rings, portable chargers and charging cables, ring sizers, and mobile applications.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: